Product Information
DEXMETHYLPHENIDATE ER 25 MG CP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.7580 per EA under NDC 00115170901. Its NADAC has been published 477 times since Aug 16, 2017.
FDA first approved this application on Jul 5, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115170901
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203614FDA Approved
7/5/2017
TE Code
AB
On Market Since
7/5/2017
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 25 MG CP has been published 477 times since Aug 16, 2017, and over the history we have for it it has declined 75.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7580 per EA |
|---|---|
| All-time high | $7.2313 (Aug 16, 2017) |
| All-time low | $1.2360 (May 22, 2024) |
| 52-week high | $2.2297 |
| 52-week low | $1.6915 |
| Median price | $2.1949 |
| Average price | $2.3420 |
| Largest weekly change | +109.4% (Jun 19, 2024) |
| Weeks tracked | 477 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dexmethylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 25 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 25 MG CP, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.7580 per EA (NDC 00115170901), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE ER 25 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 25 MG CP has declined 75.7%. It has been tracked across 477 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 25 MG CP?
Since Aug 16, 2017, the NADAC for DEXMETHYLPHENIDATE ER 25 MG CP has ranged from a low of $1.2360 (May 22, 2024) to a high of $7.2313 (Aug 16, 2017), with a median of $2.1949 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 25 MG CP?
No other NADAC-published product currently shares the active ingredient and strength of DEXMETHYLPHENIDATE ER 25 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXMETHYLPHENIDATE ER 25 MG CP?
DEXMETHYLPHENIDATE ER 25 MG CP (NDC 00115170901) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.